A prospective trial of argon laser trabeculoplasty (ALT) in narrow angle glaucoma (NAG) was undertaken. In eyes with NAG the mechanism of the glaucoma could be a combination of pupil block with subsequent irido-trabecular adhesion and trabecular damage with an increase in outflow resistance. To achieve relief of pupil block, eyes were randomly assigned to treatment with short pulsed laser iridotomy (U) with the YAG or Dye lasers, or surgical peripheral iridectomy (PI). Alter natively, argon laser iridoplasty (IP) was performed to widen the anterior chamber angle sufficiently to permit ALT. Fifty-two eyes were treated and follow-up was from 12 to 22 months. A high rate of failure to control lOP with topical medication and progression of visual field loss occurred in all treatment groups.
Iridoplasty followed by ALT was particularly unsuccessful as, in 50 per cent of cases, progressive synechial closure of the anterior chamber angle occurred follow ing treatment.
In eyes treated with PIIU and ALT, the lOP control was improved in 12 per cent, unchanged in 30 per cent and remained uncontrolled in 58 per cent. By 15 months follow-up, a satisfactory outcome (IOP<21mmHg on topical medication, visual field and acuity stable) was obtained in 24 per cent of the 33 eyes treated with PIIU and ALT. Thirty-one of these eyes showed visual field loss. Of the 10 eyes that did not receive ALT following PI or U, 90 per cent had a satisfactory outcome. Eight of these eyes showed little or no visual field loss.
The authors conclude that iridoplasty followed by ALT is an unsuitable treat ment for eyes with NAG. We further conclude that ALT is unlikely to be of benefit in eyes with NAG and visual field loss, even after pupil block has been relieved. Relief of pupil block alone may help eyes with early NAG without visual field loss.
Eyes with narrow angle glaucoma usually have a dual mechanism responsible for the raised intraocular pressure-relative pupil block and chronic outflow obstruction. The medical management of these eyes is compli cated by the inappropriateness of topical sym pathomimetics, which may cause angle crowding and, in the long term, of topical pilocarpine which may cause further shallowing of the anterior chamber (AC) and exacer bate creeping closure of the drainage angle. I A decision to operate in such cases is compli cated by choosing whether relief of relative pupil block would be sufficient or whether drainage surgery would be more appropriate. 2 The benefits of argon laser trabeculoplasty in open angle glaucoma (OAG) and of laser iridotomy for the relief of pupil block include the relative safety of these procedures, patient preference and the economic savings of out patient laser rather than in-patient surgery.
The three main aims of this trial were:
(1) to determine whether by first relieving pupil block and then performing argon laser trabeculoplasty an effective and simple out-patient procedure exists for the management of narrow angle glaucoma.
(2) to compare surgical iridectomy with laser iridotomy to determine whether the shock wave and tissue debris released in the course of short -pulsed laser iridotomy influenced the final outcome of lOP control.
(3) to determine whether eyes with NAG may be treated successfully by first widen ing the AC angle by argon laser iridoplasty' and then performing ALT.
Material and Methods
A diagnosis of narrow angle glaucoma which was suitable for inclusion in the trial was made in patients whose eyes showed the following features:
(I) Axial AC depth of � 2.5mm.
(2) Field loss detected on the Friedmann Visual
Field Analyser of at least two adjacent spots 0.4 log units above threshold or one spot 0.6 log units above threshold.
(3) Glaucomatous cupping of the optic disc.
(4) A narrow anterior chamber angle, considered capable of occlusion, with or without periph eral anterior synechial closure of the anterior chamber angle visible on Zeiss-4 mirror inden tation gonioscopy.
(5) All patients entered into this study had an intra-ocular pressure (lOP) > 21mmHg
despite maximum tolerated medical treatment.
A small number of eyes with lOP> 2lmmHg.
AC depth < 2.0mm and peripheral anterior syn echiae ( PAS). without frank glaucomatous cupping or visual field loss. mostly fellow eyes of patients with established narrow angle glaucoma. were included as these were eyes at risk of dcveloping progressive synechial closure and glaucomatous disc damage.
Patients were randomly assigned according to a computer generated random number sequence to the following treatment groups:
( I) Surgical iridectomy followed by argon laser tra beculoplasty (ALT).
(2) Laser iridotomy using either of two short pulsed lasers. the Q-switched Neodymium:
Yttrium Aluminium Garnet (Nd: YAG) laser or the pulsed Dye laser. followed by ALT at an interval of at least one month.
(360° ALT post-iridotomy/ectomy was not to be performed if the AC angle remained exten sively closed by PAS, or if a satisfactory fall in lOP followed the relief of pupil block alone.) (3) Argon laser iridoplasty followed by ALT.
After nine months of this trial no more patients were assigned to iridoplasty as it had become evident that progressive synechial closure of the drainage angle was occurring with this treatment (vide infra). 
Follow-up
Patients were closely followed up in the imme diate post-operative period following all procedures, especially to detect post-laser pressure rises. " Thereafter, follow-up was at one month. then three monthly or more often if necessary. Follow-up period for the study was to be a minimum of 12 months. At each follow-up visit, intraocular pressure (lOP) was measured by Goldmann applanation tonometry, the axial AC depth was measured with a Haag-Streit pachometer, and the anterior chamber angle width and presence of P AS noted. The recurrence of pupil block was evidenced by narrowing of the AC angle and an increase in the forward convexity of the peripheral iris which was confirmed by AC slit-image photography. " If the lOP appeared satisfactory, patients were instructed to stop taking pilocarpine two days prior to their next VISIt. After one year's follow-up, most patients had repeated intraocular pressure measurements taken over a nine hour period (phasing of lOP), and those whose control appeared poor were admitted for in-patient phasing over a 36 hour period. Friedmann visual field analysis was performed at approxi mately six monthly intervals. Throughout the study, topical medication was adjusted according to the lOP control. Where the lOP remained uncontrolled in the presence of severe or progressing visual field loss, the eye underwent filtering surgery (tra beculectomy), unless a poor surgical risk in which case systemic acetazolamide (Diamox) was added.
Visual field analysis
All visual field analysis in this study was per formed by an experienced field technician using the Friedmann Mark 2 Field Analyser. The following criteria were used to describe any field loss identified; (a) Good. Field loss less thalJ two adjacent spots 0.4 log units or one spot 0.6 log units above threshold. (b) Early. Field loss greater than above, but less than four adjacent spots 0.6 log units above threshold. (c) Bad. Field loss greater than four adjacent spots 0.6 log units above threshold.
Progression of visual field loss (YFL) YFL progression was defined as the appear ance of loss greater than four adjacent spots 0.6 log units above threshold in an area of previously normal field, or the progression from a relative to an absolute scotoma.
Results
Fifty-two eyes of 34 patients were included in the study. The age range of the patients was from 46 to 80 years, average 63 years. The axial AC depth of the eyes was from 1. 7mm to 2.Smm, average 2. 1mm. Three patients (four eyes) did not complete a 12 month follow-up. One patient (one eye) died at nine months, one patient (one eye) failed to attend after the six month follow-up and one patient (two eyes) failed to attend after the eight month fol low-up appointment. 8 eyes underwent iridoplasty followed by 3600 ALT in each case.
15 eyes underwent PI, 10 followed by 3600 ALT. 13 eyes underwent YAG LI, 11 followed by 3600 ALT, one by 1800 ALT.
16 eyes underwent Dye LI, six followed by 3600ALT, six by 1800 ALT.
Group 1 lridoplasty (IP) fo llowed by ALT. Table III This treatment option was removed from the study when it became evident that progressive synechial closure of the AC angle had occurred in 4 (50 per cent) of the eyes treated. A relative degree of pupil block was observed to be present in those eyes, evidenced by per ipheral iris bombe and gonioscopic narrowing of the AC angle. Two of these four eyes required trabeculectomy, the other two iridectomy and topical medication. Age=age of patient; ACD=axial anterior chamber depth in millimetres; ALT=degrees of anterior chamber angle treated with ALT; Field=Friedman visual field at entry to trial; PAS 6. = change in PAS post-treatment, as assessed by Zeiss 4 mirror identation gonioscopy; t =increase; 1 =decrease; Rx 6. =change in topical regimen at final outcome; Outcome=given in months post PIILIIIP; Filter=trabeculectomy to achieve lOP control; Diamox=trabeculectomy only avoided by addition of acetazolamide in eye that was poor surgical risk;
Stable=IOP controlled and visual field unchanged; VA 1 =reduction in visual acuity by > 4 lines snellen; VFL t = Visual Field Loss progression.
The remaining four eyes in this group main tained satisfactory lOP with topical medica tion, but three showed marked progression of visual field loss between 15 and 18 months follow-up.
Group 2 Surgical peripheral iridectomy followed by ALT. Table IV Over the eight to 24 months follow-up, seven eyes were considered failures as lOP remained uncontrolled and field loss pro gressed. Two of these seven eyes underwent trabeculectomy, in three acetazolamide was necessary to achieve control, and in two topical medication was increased. Of the remaining eight eyes in Group 2, control of lOP was unaffected post-operatively in five eyes and in three eyes it was possible to reduce topical medication. The visual field in these eight eyes remained stable.
Group 3 YAG laser iridotomy followed by ALT. Table V Five eyes in this group had uncontrolled lOP after treatment. Of these five, one eye showed late failure of patency of YAG iridotomy, redeveloping pupil block. This eye underwent trabeculectomy as the lOP was uncontrolled, and further visual field loss had occurred. Two other eyes with severe NAG required tra beculectomy to control the lOP, and two were controlled only with additional topical and systemic medication. In four eyes, topical medication remained unchanged after Y AG Ll/ALT, but over a 15 month follow-up period, their visual field loss showed marked progression. In four eyes the treatment was of benefit in that lOP control was achieved with a reduction of topical medication and no pro gression of visual field loss.
Group 4 Dye laser iridotomy followed by ALT. Table VI Eight eyes in this group, all with advanced field loss, had uncontrolled lOP following laser treatment and seven required tra beculectomy between three and 15 months. The remaining eye would have required tra beculectomy, but for systemic acetazolamide. In the other eight eyes, the same pre-opera tive level of treatment had to be continued post -operatively.
In analysing the results of treatment in groups 2, 3 and 4, it is helpful to consider separately the ten eyes not subsequently treated with ALT. Eight of these eyes showed little glaucomatous damage and following PI or Ll alone, their lOP control was satis factory. Of the two with 'bad' field loss, ALT was not attempted because of extensive PAS persisting after PIILl. One of these eyes remained stable, the other showed pro gressive field loss. Thus, in those eyes that did not require ALT, lOP control was improved in three, unchanged in six and continued diffi cult to control in one-a satisfactory result in 90 per cent of cases. Of the remaining 34 eyes that did receive ALT, 33 had a follow-up of 15 months or more. Of these, lOP control was improved in four eyes (12 per cent), unchanged in 11 (32 per cent) and remained uncontrolled in 19 eyes (58 per cent). Four eyes in which lOP control was unchanged fol lowing YAG Ll/ALT, showed marked pro gression of visual field loss over a 15 month follow-up.
Visual acuity
Four eyes in the study had a reduction of visual acuity. Two eyes developed cataracts reducing visual acuity by more than four lines of Snellen following Dye laser iridotomy-at one year post treatment in a 77 year old patient, and at two years post treatment in a 70 year old patient. A similar reduction in vision was seen following surgical iridectomy in two eyes, at one year post surgery in a 50 year old, and at one year post surgery in an 80 year old.
PAS formation
Significant post-treatment progression of P AS was observed in four eyes in group 1, in four eyes in group 2, in four eyes in group 3, and in three eyes in group 4. Table VII gives a summary of the outcome in treatment groups 2, 3 and 4 in those eyes followed up for 15 months or more. Control of lOP was improved in 4 eyes (12 per cent) unchanged in 10 eyes (30 per cent) and remained uncontrolled in 19 eyes (58 per cent). Those eyes with stable visual fields and visual acuities, and lOP less than 21 mmHg are shown in Table VIII . Three eyes (33 per for filtering surgery. 7 However, ALT is unsuitable for patients with NAG as the inflammation produced may lead to PAS for mation and progressive angle closure. � Wise reports that he has observed a tendency in medically treated eyes with OAG to develop creeping angle closure and therefore now per forms AL iridotomies in 30 per cent of eyes he treats with ALT to deepen the peripheral AC and prevent the formation of PAS. 9
In an ageing glaucomatous population as enlargement of the crystalline lens leads to progressive shallowing of the anterior cham ber,lO.ll the prevalence of NAG must rise, thereby rendering less eyes suitable for ALT. In addition, pilocarpine may be responsible for narrowing the AC anglel and some patients may have unsuspected exfoliation syndromel2-in which there has been shown to be a high incidence of narrowing and closure of the AC angle.13 Similarly, eyes with congenitally small anterior segments will be unsuitable for ALT as the drainage angle will be crowded by the peripheral iris.
Some eyes with raised lOP in which topical medication is inappropriate may therefore be unsuitable for ALT, and may require filtering surgery. However, filtration surgery requires in-patient treatment, and introduces the risk of infection, flat AC, malignant glaucoma and, in phakic patients, of worsening lens opacities. 14 The benefits of relief of pupil block by iridectomy/iridotomy in eyes with chronic angle closure glaucoma are well knownls.IY and this is especially so in eyes with raised lOP with little in the way of glaucomatous damage.IH Where cupping of the optic disc and visual field loss are present, however, iridec tomy alone is unlikely to be successful in reducing the lOP to safe levels.16.IR With the advent of LI, some authors, however, recom mend argon Ll in all cases of chronic angle closure as post-operatively, control may be more easily achieved with topical medication.2o. 21.22 This study sought to relieve any pupil block present in eyes with NAG, and then, if lOP was still raised, to improve outflow by per forming ALT. Performing an iridotomyl iridectomy should relieve pupil block, widen the AC angle and prevent the progression of PAS. 1 8 .1 � . 22 ALT may then be performed on the more open angle without the risk of exac erbating PAS. A preliminary study of this treatment option showed a small fall in the lOP, additional to that produced by medical treatment, over a six to 12 month follow-up period. 23 The results of treatment in the present study were, however, disappointing with a long-term success rate of 24 per cent. (Table  VIlI) .
In the present study, the progressive syn echial closure of the AC angle observed to follow iridoplasty/ALT in 50 per cent of cases led to the abandonment of this treatment.
lrido-trabecular contact will result in perma nent synechiae formation once the abrading action of contact has denuded the surface layer of cells covering these tissues. Laser damage to these surface cells will promote the tendency to adhesion between iris and TM.24
The authors agree with the opinion of Wise that iridoplasty is an unsuitable method of deepening the peripheral AC prior to ALT as this deepening is only temporary.9
In groups 2, 3 and 4 relief of pupil block appeared to be most helpful in those eyes without visual field loss. Of the eight eyes without visual field loss none required ALT to keep the lOP controlled and none suffered further field loss. By 15 months follow-up of the 33 eyes that required ALT following PIILI, 58 per cent came to filtering surgery or required the addition of systemic acetazolamide therapy. Thirty-one of these eyes had visual field loss.
Particularly disappointing in this study was the progression of visual field loss seen in the three eyes apparently successfully treated with iridoplasty and ALT, and four eyes with successful lOP control following YAG LI and ALT. As these patients continued to be treated with topical medication, it may be that their compliance was pOOr. 25 However, pro gression of field loss has also been reported following successful lowering of lOP after tra beculectomy26 and also ALTY In eyes with OAG, ALT has been shown to be effective in reducing the IOp6.7H with suc cess rates as high as 85-90 per cent. 5 In this study, however, ALT resulted in improved lOP control in only 12 per cent of eyes. Several possible explanations may account for this difference: (a) Difficulties with technique of AL T in eyes with NAG. Even though the angle was widened by IP/PI or LI prior to ALT, the target area remains less easily visualised than in an eye with OAG and the more oblique direction of the aiming beam may result in a less precisely focused spot. (b) Differences in tissue response to ALT. To minimise the risk of PAS formation post ALT in this study, the anterior TM was treated.2 8 However, this may have resulted in further outflow obstruction due to the endothelial cellular prolifera tive changes which have been described by Van der Zypen et al. following anterior TM ALT. 29 (c) The mechanism of outflow obstruction in NAG may differ from that of OAG. The exact mechanism of lOP reduction that is seen following successful ALT in OAG is conjectural, but tightening of the trabecu lar ring thereby opening up the collapsed spaces of the TM has been suggested. 30
In those eyes that underwent ALT after LI or SI, 10 eyes (29 per cent) showed an increase of PAS over the period of follow-up. In the 10 eyes not treated with ALT, progression of PAS only occurred in one (10 per cent). For mation of P AS is a recognised complication of ALT in OAG2H and despite widening of the AC angle after relief of pupil block, it may be that the laser energy deposited in the still rela tively small space causes sufficient tissue damage to lead to PAS formation.
The study also served to compare the long term effects of surgical iridectomy with short pulsed laser iridotomy. Surgical iridectomy is without danger to the endothelium31 but carries the risks of infection, malignant glaucoma and worsening pre-existing catar act. 32 Although out-patient procedures, LI and ALT are not without complications. Sig nificant elevations of lOP after Ll are com mon in eyes with chronic angle closure glaucoma, may be prolonged and may require emergency in-patient treatment. 4 Endothelial damage may also follow short-pulsed LI, although, in the short term, this has not been shown to be clinically significant. 31 Significant elevations of lOP may also occur after AL T. 7.27 Therefore, in addition to the imme diate risk to the eye from raised lOP, there may be long-term damage to the outflow system from tissue debris and shock-wave release associated with short-pulsed laser iridotomy. However, the treatment failure rate was very similar in Groups 2, 3 and 4 and therefore these theoretical disadvantages associated with LI do not seem to be prejudi cial to the longer-term control of lOP. Because of the small number of eyes in each treatment group and the differing degree of glaucomatous damage in the eyes a statistical analysis of the results was not possible.
One potential danger of laser iridotomy in NAG eyes is failure to relieve pupil block. Where this occurs, whether due to late closure or inadequate size of the iridotomy, pro gressive angle closure will occur, exacerbated ')y the inflammation produced by the LI and AL T. This occurred in one eye in this study after YAG LI and may easily be overlooked in follow-up without frequent and careful gonio scopy. Failure of YAG LI has also been reported elsewhere4.33 and in a series of 200 cases, Spaeth found nine per cent of YAG Lis required retreatment. 34
Examination of Tables IV, V and VI shows that eyes with 'bad' visual field loss pre-treat ment were the most likely to require filtering surgery to achieve control. The poorest results were obtained in the Dye LIIALT group, but a greater proportion of eyes in this group had 'bad' visual field loss pre treatment.
Four eyes in this study developed lens opacities-two after dye LI and two after PI. However, these lens opacities were not neces sarily the result of treatment. Acute focal lens opacities have been reported following LI with the dye laser,3 but no acute damage was observed in the two cases in this study and both patients were elderly with pre-existing nuclear sclerosis. Similarly, the cataracts that followed PI may not have been related to surgery. In one patient, as only one eye had received treatment and the progression to cat aract was bilateral and symmetrical, this lens opacity was unlikely to be a result of surgery. The other patient to develop a cataract after PI was 70 years old and had pre-existing nuclear sclerosis.
Conclusions
(1) Argon laser iridoplasty followed by ALT is an unsuitable treatment for eyes with shallow anterior chambers and NAG. (2) In eyes with normal visual fields that nevertheless have a diagnosis of NAG (shallow AC, raised lOP and early PAS) LI or SI is indicated. Relieving pupil block allows the safe use of medical therapy, reverses the trend to develop progressive angle closure and may in itself cause a fall in lOP. (3) Eyes with established NAG (shallow AC, field loss, optic disc cupping and PAS) are unsuitable for treatment with ALT, even where successful relief of pupil block is achieved. To the high rate of failure to control lOP (58 per cent), must be added the mor bidity of possible post-laser pressure rise and extension of PAS. Furthermore, such treat ment requires much time to perform and close supervision in the immediate and long-term follow-up periods. (4) In eyes with NAG with advanced glaucomatous damage of the optic nerve head and visual field loss, control of lOP after relief of pupil block remains difficult. Such eyes may be better treated by filtering surgery thus avoiding the delay and complications that may be encountered when a trial of PI or LI fol lowed by topical medication is embarked upon.
